Engel J, Rocha L L
Department of Neurology & Anatomy, UCLA School of Medicine.
Epilepsy Res Suppl. 1992;9:341-9; discussion 350.
Postictal symptoms can be disabling in themselves, but their underlying substrates may endure, giving rise to epilepsy-induced interictal behavioral disorders. Chronic temporal lobe epilepsy is reported to be associated with a variety of interictal behavioral changes which often take the form of affective disturbances. Depression, among the more common interictal psychological dysfunctions suffered by patients with temporal lobe seizures, could reflect epilepsy-induced alterations in normal opioid peptide mechanisms. In experimental animal models, certain postictal behaviors have been shown to be opioid-mediated. Furthermore, an experimental model of interictal behavioral disturbance resembles stimulation-induced defensive rage, which can be relieved by intracerebral administration of opioid peptides. Defensive rage is a species-specific behavior encountered in cats. Its correlate in humans would be difficult to predict in view of the stronger cortical control; however, it may manifest rather as insecurity, irritability, and perhaps depression. Extrapolation of animal experiments would suggest that depression and certain other common postictal and interictal affective disturbances seen in patients with temporal lobe seizures reflect mechanisms more related to opiate withdrawal, than to direct opiate actions. The activity-induced plasticity associated with recurrent temporal lobe seizures, therefore, should result in changes in opioid function that predispose to withdrawal phenomena. Limbic seizures induce enhanced enkephalin synthesis lasting for up to 2 weeks. Recurrent seizures in experimental animals, however, cause paradoxical up-regulation of mu opiate receptors. Patients with temporal lobe epilepsy demonstrate enhanced mu receptor binding in the neocortex of the epileptogenic temporal lobe on PET. The reasons for this enduring interictal effect are not clear. Nevertheless, if animals or patients become dependent on enhanced endogenous opioid activity as a result of seizures, and also have up-regulation of mu receptors, then severe withdrawal effects, such as defensive rage in cats or depression in humans, might be expected when seizures do not recur frequently. Plotting the time course of mRNAenk and enkephalin expression after seizures, and the time course of symptoms of interictal behavioral disturbances, may demonstrate a temporal relationship that supports this hypothesis. For instance, depression or other withdrawal symptoms might only occur when the interval between seizures is greater than the duration of seizure-induced enkephalin synthesis.(ABSTRACT TRUNCATED AT 400 WORDS)
发作后症状本身可能会使人丧失能力,但其潜在的基础可能会持续存在,从而引发癫痫诱发的发作间期行为障碍。据报道,慢性颞叶癫痫与多种发作间期行为变化有关,这些变化通常表现为情感障碍。抑郁是颞叶癫痫患者较常见的发作间期心理功能障碍之一,可能反映了癫痫引起的正常阿片肽机制的改变。在实验动物模型中,某些发作后行为已被证明是由阿片介导的。此外,一种发作间期行为障碍的实验模型类似于刺激诱发的防御性愤怒,脑内注射阿片肽可以缓解这种愤怒。防御性愤怒是猫身上出现的一种物种特异性行为。鉴于人类有更强的皮质控制,很难预测其在人类身上的对应表现;然而,它可能表现为不安全感、易怒,也许还有抑郁。动物实验的推断表明,颞叶癫痫患者中出现的抑郁和其他一些常见的发作后及发作间期情感障碍,反映的机制更多地与阿片类药物戒断有关,而不是与阿片类药物的直接作用有关。因此,与复发性颞叶癫痫相关的活动诱导可塑性应会导致阿片类药物功能的变化,从而易引发戒断现象。边缘系统发作会导致脑啡肽合成增强,持续长达2周。然而,实验动物的复发性发作会导致μ阿片受体的反常上调。颞叶癫痫患者在PET检查中显示,致痫颞叶的新皮质中μ受体结合增强。这种持久的发作间期效应的原因尚不清楚。然而,如果动物或患者由于癫痫发作而依赖增强的内源性阿片类药物活性,并且μ受体也上调,那么当癫痫发作不频繁复发时,可能会出现严重的戒断效应,如猫的防御性愤怒或人类的抑郁。绘制癫痫发作后mRNAenk和脑啡肽表达的时间进程,以及发作间期行为障碍症状的时间进程,可能会显示出支持这一假设的时间关系。例如,抑郁或其他戒断症状可能只在发作间隔大于发作诱导的脑啡肽合成持续时间时才会出现。(摘要截选至400字)